B. Evans

3.7k total citations · 1 hit paper
56 papers, 2.9k citations indexed

About

B. Evans is a scholar working on Molecular Biology, Organic Chemistry and Cellular and Molecular Neuroscience. According to data from OpenAlex, B. Evans has authored 56 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Molecular Biology, 18 papers in Organic Chemistry and 18 papers in Cellular and Molecular Neuroscience. Recurrent topics in B. Evans's work include Neuropeptides and Animal Physiology (15 papers), Chemical Synthesis and Analysis (11 papers) and Peptidase Inhibition and Analysis (7 papers). B. Evans is often cited by papers focused on Neuropeptides and Animal Physiology (15 papers), Chemical Synthesis and Analysis (11 papers) and Peptidase Inhibition and Analysis (7 papers). B. Evans collaborates with scholars based in United States, Russia and United Kingdom. B. Evans's co-authors include Kenneth E. Rittle, Mark G. Bock, Roger Freidinger, Robert M. DiPardo, Daniel F. Veber, Willie L. Whitter, Paul Anderson, James P. Springer, G. F. Lundell and Victor J. Lotti and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and Biochemistry.

In The Last Decade

B. Evans

54 papers receiving 2.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Methods for drug discovery: development of potent, selective, orally effective cholecystokinin antagonists

1988 1.2k citations B. Evans, Kenneth E. Rittle et al. Journal of Medicinal Chemistry profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
B. Evans United States	21	1.6k	1.4k	660	264	232	56	2.9k
Mark G. Bock United States	29	1.9k 1.2×	1.8k 1.3×	875 1.3×	326 1.2×	330 1.4×	109	3.8k
Kenneth E. Rittle United States	20	1.3k 0.8×	1.3k 1.0×	585 0.9×	278 1.1×	213 0.9×	38	2.5k
Robert M. DiPardo United States	21	1.5k 0.9×	1.4k 1.0×	680 1.0×	260 1.0×	228 1.0×	57	2.7k
Raymond S.L. Chang United States	31	2.7k 1.7×	1.6k 1.2×	1.6k 2.4×	374 1.4×	277 1.2×	114	4.7k
Willie L. Whitter United States	13	1.1k 0.7×	1.0k 0.7×	528 0.8×	228 0.9×	178 0.8×	19	2.0k
Bruno Pfeiffer France	36	1.6k 1.0×	2.4k 1.7×	259 0.4×	483 1.8×	210 0.9×	145	3.8k
James F. Kerwin United States	26	997 0.6×	1.1k 0.8×	413 0.6×	194 0.7×	86 0.4×	77	2.8k
H. Timmerman Netherlands	26	1.5k 1.0×	614 0.4×	477 0.7×	286 1.1×	167 0.7×	91	3.1k
William J. Greenlee United States	34	2.2k 1.4×	2.0k 1.4×	642 1.0×	338 1.3×	251 1.1×	161	4.5k
Shaun R. Stauffer United States	35	1.9k 1.2×	1.4k 1.0×	1.1k 1.6×	249 0.9×	230 1.0×	96	4.2k

Countries citing papers authored by B. Evans

Since Specialization

Citations

This map shows the geographic impact of B. Evans's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by B. Evans with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites B. Evans more than expected).

Fields of papers citing papers by B. Evans

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by B. Evans. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by B. Evans. The network helps show where B. Evans may publish in the future.

Co-authorship network of co-authors of B. Evans

This figure shows the co-authorship network connecting the top 25 collaborators of B. Evans. A scholar is included among the top collaborators of B. Evans based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with B. Evans. B. Evans is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Williams, Peter D., Mark G. Bock, B. Evans, et al.. (1999). Nonpeptide oxytocin antagonists: Analogs of L-371,257 with improved potency. Bioorganic & Medicinal Chemistry Letters. 9(9). 1311–1316. 13 indexed citations

Williams, Peter, et al.. (1998). Progress in the Development of Oxytocin Antagonists for Use in Preterm Labor. Advances in experimental medicine and biology. 395. 473–479. 32 indexed citations

Salata, Joseph J., et al.. (1998). A Novel Benzodiazepine that Activates Cardiac Slow Delayed Rectifier K+ Currents. Molecular Pharmacology. 54(1). 220–230. 129 indexed citations

Bock, Mark G., Robert M. DiPardo, B. Evans, et al.. (1994). ChemInform Abstract: Development of 1,4‐Benzodiazepine Cholecystokinin Type B Antagonists.. ChemInform. 25(26). 3 indexed citations

Pettibone, Douglas J., Bradley V. Clineschmidt, Mark G. Bock, et al.. (1993). Development and pharmacological assessment of novel peptide and nonpeptide oxytocin antagonists. Regulatory Peptides. 45(1-2). 289–293. 4 indexed citations

Evans, B., G. F. Lundell, Kevin F. Gilbert, et al.. (1993). Nanomolar-affinity, non-peptide oxytocin receptor antagonists. Journal of Medicinal Chemistry. 36(25). 3993–4005. 19 indexed citations

Pettibone, Douglas J., Bradley V. Clineschmidt, Edward V. Lis, et al.. (1993). Identification of an orally active, nonpeptidyl oxytocin antagonist.. Journal of Pharmacology and Experimental Therapeutics. 264(1). 308–314. 22 indexed citations

Evans, B., James L. Leighton, Kenneth E. Rittle, et al.. (1992). Orally active, nonpeptide oxytocin antagonists. Journal of Medicinal Chemistry. 35(21). 3919–3927. 64 indexed citations

Bock, Mark G., Robert M. DiPardo, B. Evans, et al.. (1990). Cholecystokinin-A receptor ligands based on the .kappa.-opioid agonist tifluadom. Journal of Medicinal Chemistry. 33(1). 450–455. 16 indexed citations

10.

Bock, Mark G., Robert M. DiPardo, B. Evans, et al.. (1989). Benzodiazepine gastrin and brain cholecystokinin receptor ligands; L-365,260. Journal of Medicinal Chemistry. 32(1). 13–16. 250 indexed citations

11.

Bock, Mark G., Robert M. DiPardo, B. Evans, et al.. (1988). Cholecystokinin antagonists. Synthesis and biological evaluation of 4-substituted 4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepines. Journal of Medicinal Chemistry. 31(1). 176–181. 16 indexed citations

12.

Bock, Mark G., Robert M. DiPardo, B. Evans, et al.. (1988). Cholecystokinin antagonists. Synthesis and biological evaluation of 3-substituted 1,4-benzodiazepin-2-amines. Journal of Medicinal Chemistry. 31(1). 264–268. 18 indexed citations

13.

Evans, B., Kenneth E. Rittle, Mark G. Bock, et al.. (1988). Methods for drug discovery: development of potent, selective, orally effective cholecystokinin antagonists. Journal of Medicinal Chemistry. 31(12). 2235–2246. 1177 indexed citations breakdown →

14.

Bock, Mark G., Robert M. DiPardo, B. Evans, et al.. (1987). Renin inhibitors. Statine-containing tetrapeptides with varied hydrophobic carboxy termini. Journal of Medicinal Chemistry. 30(10). 1853–1857. 9 indexed citations

15.

Rittle, Kenneth E., B. Evans, Mark G. Bock, et al.. (1987). A new amine resolution method and its application to 3-aminobenzodiazepines. Tetrahedron Letters. 28(5). 521–522. 20 indexed citations

16.

Bock, Mark G., Robert M. DiPardo, B. Evans, et al.. (1987). An expedient synthesis of 3-amino-1,3-dihydro-5-phenyl-2H-1,4-benzodiazepin-2-one. Tetrahedron Letters. 28(9). 939–942. 14 indexed citations

17.

Bock, Mark G., Robert M. DiPardo, Kenneth E. Rittle, et al.. (1986). Cholecystokinin antagonists. Synthesis of asperlicin analogs with improved potency and water solubility. Journal of Medicinal Chemistry. 29(10). 1941–1945. 24 indexed citations

18.

Evans, B., et al.. (1978). ChemInform Abstract: SYNTHESES AND PROPERTIES OF MESO‐METHYL PORPHYRINS AND CHLORINS. Chemischer Informationsdienst. 9(13). 3 indexed citations

19.

Taylor, Edward C. & B. Evans. (1971). Condensation of phosphonate anions with 4-amino-5-nitrosopyrimidines: a new pteridine synthesis. Journal of the Chemical Society D Chemical Communications. 189–189. 3 indexed citations

20.

Shefter, Eli, B. Evans, & Edward C. Taylor. (1971). X-ray structures of 7-aminofurazano [3,4-d]pyrimidine and 7-amino-1,2,5-thiadiazolo[3,4-d]pyrimidine. Journal of the American Chemical Society. 93(26). 7281–7285. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact